OptimizeRx Corp. (NASDAQ: OPRX), a healthcare technology company specializing in AI-driven solutions for life sciences, has announced a $35 million senior secured credit facility with Fifth Third Bank. The facility includes a $25 million term loan and a $10 million revolving credit line, which remained undrawn at closing. Roth Capital Partners acted as financial advisor for the transaction.
The new financing is expected to bolster OptimizeRx's platform, which leverages artificial intelligence tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT). These tools enable life science brands to deliver timely, relevant, and hyper-local engagement with healthcare providers (HCPs) and patients. By bridging HCP and direct-to-consumer (DTC) strategies, the company aims to create synchronized marketing solutions that accelerate treatment decisions and improve patient outcomes.
For business leaders, this announcement signals OptimizeRx's intent to scale its operations in the competitive healthcare technology market. The credit facility provides financial flexibility to invest in product development, sales, and potential acquisitions. As the healthcare industry increasingly adopts digital and AI-driven marketing, OptimizeRx's platform addresses the need for privacy-safe, patient-centric engagement tools.
The company's technology focuses on delivering life-changing therapies to the right patients at the right time, a critical factor in an era where personalized medicine and targeted outreach are becoming standard. With head offices in Waltham, Massachusetts, OptimizeRx partners with leading pharmaceutical and life sciences companies globally. The additional capital could accelerate the adoption of its platform, potentially reshaping how brands interact with healthcare ecosystems.
Industry observers note that AI-driven marketing solutions are gaining traction as healthcare organizations seek to improve ROI on marketing spend while complying with privacy regulations. OptimizeRx's emphasis on hyper-local targeting and real-time engagement positions it to capture market share. The credit facility, arranged through Fifth Third Bank, reflects confidence in the company's growth trajectory and its ability to generate future cash flows.
Roth Capital Partners' involvement as financial advisor adds credibility to the transaction. The undrawn revolver provides a cushion for working capital needs or opportunistic investments. For readers, the development highlights the increasing convergence of AI, healthcare, and finance, with implications for how treatments are marketed and delivered.
More details on the announcement can be found at this link. Information about OptimizeRx and its platform is available at www.optimizerx.com.
